+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cefalexin"

Urinary Tract Infection Treatment Global Market Report 2024 - Product Thumbnail Image

Urinary Tract Infection Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2023
  • 270 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Thumbnail Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • October 2023
  • 135 Pages
  • China
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Cefalexin is an antibiotic used to treat a variety of bacterial infections, including those caused by Streptococcus, Staphylococcus, and E. coli. It is a member of the cephalosporin class of antibiotics, which are used to treat a wide range of infections, including those caused by Gram-positive and Gram-negative bacteria. Cefalexin is commonly used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to treat some sexually transmitted diseases, such as gonorrhea. Cefalexin is a widely used antibiotic in the infectious diseases drugs market. It is generally well tolerated and has a low risk of side effects. It is available in both oral and intravenous forms, and is often prescribed as a first-line treatment for bacterial infections. Some companies in the Cefalexin market include Pfizer, GlaxoSmithKline, Merck, and Sanofi. Show Less Read more